|Articles|June 13, 2022
Syner-G Biopharma Group Appoints Ron Kraus as CEO
Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.
Advertisement
Syner-G BioPharma Group announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Kraus has more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.
Prior to joining Syner-G, Kraus was Chief Operating Officer at Cytel. He succeeds Syner-G’s founder, Prabu Nambiar, PhD, MBA, RAC, as CEO.
Read more about Kraus' appointment
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
2
The Evolving Relationship Between FDA and Biotech
3
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
4
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
5